Sonavex Receives FDA 510(k) Clearance for EchoMark & EchoMark LP Tissue Markers

Thursday, June 7, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

Baltimore-based medical device company gets nod from FDA to market the first product in its portfolio, a soft tissue marker for ultrasound visualization

BALTIMORE, June 7, 2018 /PRNewswire-PRWeb/ -- Sonavex, Inc., a privately held medical device company focused on improving

surgical patient outcomes with point-of-care imaging technologies, announced today that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its EchoMark and EchoMark LP soft tissue markers.

EchoMark and EchoMark LP (Low Profile) are highly echogenic, resorbable polymeric implants used for marking soft tissue sites in surgical patients. EchoMark's unique ultrasound reflective properties, created by a novel manufacturing technique, and 3-dimensional shape enable surgeons to precisely mark surgical sites for clear ultrasound visualization during critical follow-up evaluations.

EchoMark is the first product in Sonavex's growing portfolio of new technologies to receive FDA clearance. "Regulatory clearance is a significant milestone in Sonavex's mission to bring novel point-of-care medical imaging solutions to patients for improved surgical outcomes," said David Narrow, CEO of Sonavex. "This achievement is a testament to the strength of our team and commitment of our collaborators. We are pleased to bring EchoMark to market and look forward to further expanding our product line in the near future."

"After four years of development and testing, we are excited to start using EchoMark at the bedside," said Devin O'Brien Coon, MD, Sonavex President and Study Director for the pivotal 510(k) study. "We believe that surgical ultrasound is an underutilized tool with the potential to dramatically change patient management – for the better."

In addition to a recently closed Series A financing, last month the company was awarded a Small Business Innovation Research (SBIR) Phase II supplement grant from the National Science Foundation to support further research and development efforts for next-generation ultrasound technologies.

About Sonavex, Inc. Sonavex, Inc. is a Baltimore-based medical device company originally spun out of Johns Hopkins. The company has developed a portfolio of novel ultrasound solutions to visualize and quantify critical clinical data for improved outcomes and reduced costs in new surgical applications. For more information, please visit http://www.sonavex.com.

 

SOURCE Sonavex, Inc.

Advertisement


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store